These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22258722)

  • 1. Structural remodeling and mechanical function in heart failure.
    Leonard BL; Smaill BH; LeGrice IJ
    Microsc Microanal; 2012 Feb; 18(1):50-67. PubMed ID: 22258722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.
    Westermann D; Lindner D; Kasner M; Zietsch C; Savvatis K; Escher F; von Schlippenbach J; Skurk C; Steendijk P; Riad A; Poller W; Schultheiss HP; Tschöpe C
    Circ Heart Fail; 2011 Jan; 4(1):44-52. PubMed ID: 21075869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac remodeling and failure From molecules to man (Part II).
    Fedak PW; Verma S; Weisel RD; Li RK
    Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing the remodeling process in heart failure: basic mechanisms and laboratory results.
    Francis GS
    Curr Opin Cardiol; 1998 May; 13(3):156-61. PubMed ID: 9649937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A look between the cardiomyocytes: the extracellular matrix in heart failure.
    Miner EC; Miller WL
    Mayo Clin Proc; 2006 Jan; 81(1):71-6. PubMed ID: 16438481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix dynamics in heart failure: a prospect for gene therapy.
    Tyagi SC
    J Cell Biochem; 1998 Mar; 68(4):403-10. PubMed ID: 9493904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
    Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
    Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
    Creemers EE; Pinto YM
    Cardiovasc Res; 2011 Feb; 89(2):265-72. PubMed ID: 20880837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac remodeling and failure: from molecules to man (Part III).
    Fedak PW; Verma S; Weisel RD; Skrtic M; Li RK
    Cardiovasc Pathol; 2005; 14(3):109-19. PubMed ID: 15914295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.
    Seeland U; Kouchi I; Zolk O; Itter G; Linz W; Böhm M
    J Mol Cell Cardiol; 2002 Feb; 34(2):151-63. PubMed ID: 11851355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of diastolic dysfunction in heart failure.
    Borlaug BA; Kass DA
    Trends Cardiovasc Med; 2006 Nov; 16(8):273-9. PubMed ID: 17055383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload.
    Janicki JS; Brower GL; Gardner JD; Forman MF; Stewart JA; Murray DB; Chancey AL
    Cardiovasc Res; 2006 Feb; 69(3):657-65. PubMed ID: 16376324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.
    Foronjy RF; Sun J; Lemaitre V; D'Armiento JM
    Hypertens Res; 2008 Apr; 31(4):725-35. PubMed ID: 18633185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix remodeling in hypertensive heart disease.
    Shirwany A; Weber KT
    J Am Coll Cardiol; 2006 Jul; 48(1):97-8. PubMed ID: 16814654
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging concepts in cardiac matrix biology.
    Espira L; Czubryt MP
    Can J Physiol Pharmacol; 2009 Dec; 87(12):996-1008. PubMed ID: 20029536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch.
    Atance J; Yost MJ; Carver W
    J Cell Physiol; 2004 Sep; 200(3):377-86. PubMed ID: 15254965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.